Why VectorXcellerator?
Early development decisions can have long-term implications for cell and gene therapy programmes, particularly when it comes to vector design, process development, manufacturability, and scalability. VectorXcellerator has been created to support organisations developing promising early-stage programmes by generating feasibility-level data and technical confidence to guide next development steps, with no obligation for future commercial engagement.
What's Included?
A typical feasibility study:
- Project Initiation Enabling Activities
- Cloning of the Applicant’s gene of interest into OXB genome plasmid backbone(s)
- Small-scale upstream and downstream process evaluation
- A defined set of platform analytical assays
Programme Outputs:
- Genome plasmid(s) constructed as specified
- Slide deck summarising key findings
- Viral vector samples (subject to availability and for research purposes only)
Who is VectorXcellerator Designed for?
VectorXcellerator is designed to support organisations that are:
- Advancing early-stage cell and gene therapy programmes
- Seeking to address defined technical or feasibility questions related to viral vector development and manufacturing
- Looking for specialised viral vector expertise to inform early development decisions
Apply today
If VectorXcellerator is a good fit for your programme, we invite you to apply by completing the application form and submitting to vectorxcellerator@oxb.com by 10th Apr 2026 | 23:59 (GMT). Please enter your details below to request the application form.
More details can be found in the Programme Guidance Document >
We understand that some of the information provided by you in the application form may be of a confidential nature – if you require a confidentially agreement, please email us at vectorxcellerator@oxb.com.
For questions, please contact: vectorxcellerator@oxb.com
Selection Process and Timeline
Applications will be reviewed by a cross-functional OXB panel with expertise in viral vector development and manufacturing. Due to the selective nature of the initiative, only a small number of applications will be successful. More details can be found in the programme guidance document here >
Frequently Asked Questions
There is no cost to apply. Selected feasibility studies are fully funded by OXB.
Selected companies will receive a feasibility-level technical study aligned to pre-agreed objectives. The precise scope and deliverables will be confirmed prior to project initiation.
Applicants are reviewed by a cross-functional OXB panel and assessed holistically across several factors, including scientific and technical readiness, alignment with OXB’s platform capabilities, team experience, and robustness of development plan.
No. Participation in VectorXcellerator does not imply any obligation for future commercial engagement by either party.
A successful feasibility study may inform future discussions; however, any subsequent collaboration would be subject to separate evaluation and agreement and is not guaranteed as part of the VectorXcellerator initiative.
All applicants will be notified of the outcome. Due to the nature of the initiative, OXB may not be able to provide detailed individual feedback.
OXB reserves the right to modify, suspend, or withdraw the VectorXcellerator initiative prior to commencement of any feasibility study.